11月11日 - ** 制药商Soleno Therapeutics SLNO.O股价盘前上涨8%至50.05美元
** Soleno与Jefferies LLC达成协议，将回购1亿美元的Soleno普通股
** 该公司表示，它将支付1亿美元的首付款，并根据周一46.31美元/股的收盘价，首先收到约150万股股票。
** 最终股票数量将根据回购交易条款进行调整
** 首席执行官 Anish Bhatnagar 表示："这些行动表明，我们对商业化上市充满信心，VYKAT XR 将成为普拉德-威利综合征多食症患者的基础疗法。
** 回购预计将于 2026 年第一季度完成
** 12家券商中有9家将该股评为 "买入 "或更高评级，3家为 "持有"；他们的PT中值为112.50美元--数据由LSEG编制
** 截至上次收盘，该股今年累计上涨约 3
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.